Free Trial
CVE:LXG

LexaGene (LXG) Stock Price, News & Analysis

LexaGene logo
C$0.10 -0.03 (-19.23%)
(As of 02/21/2023)

About LexaGene Stock (CVE:LXG)

Key Stats

Today's Range
C$0.10
C$0.14
50-Day Range
C$0.11
C$0.11
52-Week Range
C$0.07
C$0.31
Volume
2.14 million shs
Average Volume
170,061 shs
Market Capitalization
C$14.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets. Its automated pathogen detection platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. The company was incorporated in 2007 and is headquartered in Beverly, Massachusetts.

Receive LXG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LexaGene and its competitors with MarketBeat's FREE daily newsletter.

LXG Stock News Headlines

Pamapol Ord Share Price (0LXG)
Biosynex SA ALBIO
“Trump Trades” You’ve Got to Make
These Stocks are the Best “Trump Trades” Free e-book reveals sectors – and stocks within them – likely to pop now that Donald Trump has been re-elected
Cyclopharm Ltd CYC
Lexagene Holdings Inc (LXGh)
IIROC Trading Halt - LXG
See More Headlines

LXG Stock Analysis - Frequently Asked Questions

LexaGene's stock was trading at C$0.11 at the beginning of 2024. Since then, LXG stock has increased by 0.0% and is now trading at C$0.11.
View the best growth stocks for 2024 here
.

Shares of LXG stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that LexaGene investors own include Citius Pharmaceuticals (CTXR), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Athersys (ATHX), Bionano Genomics (BNGO), EQT (EQT) and Inovio Pharmaceuticals (INO).

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
41
Year Founded
N/A

Profitability

Net Income
C$-8,540,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$110,927.00
Cash Flow
C$0.00 per share
Book Value
C$0.01 per share

Miscellaneous

Free Float
N/A
Market Cap
C$14.77 million
Optionable
Not Optionable
Beta
2.26
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (CVE:LXG) was last updated on 11/22/2024 by MarketBeat.com Staff
From Our Partners